Back
Open Access

Development and characteristics of immunoturbidimetric NT-proBNP assay based on antibodies targeting glycosylation-free regions of NT-proBNP

Session: Progress in heart failure diverse biomarkers
Topic: Biomarkers
Speaker: Doctor A. Havelka (Moss, NO)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Aleksandra Havelka

Gentian AS, Moss (Norway)
0 follower

6 more presentations in this session

Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

Speaker: Associate Professor C. Hage (Stockholm, SE)

Access
Abstract
Like
Thumbnail

Rationale and design of the Biobank of SwedeHF - exploring pathophysiological aspects of heart failure

Speaker: Associate Professor C. Hage (Stockholm, SE)

Access
Abstract
Like
Thumbnail

Real-world monocentric experience of early impact of SGLT2 inhibitors on NT-proBNP levels in heart failure

Speaker: Doctor S. Prosperi (Rome, IT)

Access
Abstract
Like
Thumbnail

Role of biomarkers of cardiovascular remodeling and inflammation in estimation of prognosis in patients with chronic heart failure

Speaker: Doctor E. Tyleckova (Prague, CZ)

Access
Abstract
Like
Thumbnail

Determination of NT-proBNP levels to define heart overload/failure and the effect of triple-inhaled therapy in older COPD patients: a multicenter longitudinal study

Speaker: Professor R. Sarzani (Ancona, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Progress in heart failure diverse biomarkers

Speakers: Doctor A. Havelka, Associate Professor C. Hage, Associate Professor C. Hage, Doctor S. Prosperi, Doctor E. Tyleckova...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources